Cronos Group has uplisted from the International Market Exchange at NASDAQ (NDAQ) to the Nasdaq Global Market. The new ticker will be CRON.
MedReleaf announced that it has entered into an agreement to acquire 1 million square feet of existing greenhouse infrastructure on a 669-acre property in Exeter, Ontario and 95 acres of adjacent land for $21.5 million in cash and 225,083 common shares of MedReleaf
Friday Night Inc. (TGIFF) has acquired as a wholly owned subsidiary Spire Secure Logistics Inc. a Canadian private company specializing in security, intelligence, and compliance with international clients and expertise in both the regulated cannabis industry and other sectors. In addition to that Friday Night Inc. told investors that it had struck a letter of intent to acquire 100% of the Harvest Foundation – a cultivation facility, which lies next to Friday Night’s production subsidiary Alternative Medicine Association in Las Vegas, Nevada. Friday Night also terminated its plan to acquire Body & Mind.
GW Pharmaceuticals plc (GWPH) has been granted orphan drug status by the European Medicines Agency (EMA) for the treatment of tuberous sclerosis (TS). The EMA orphan designation is a status assigned to a medicine intended for use against a rare condition allows a pharmaceutical company to benefit from incentives like reduced fees and protection from competition once the medicine is placed on the market.
MPX Bioceutical Corp. (MPXEF) reported its third-quarter earnings. Dispensary cannabis sales for the quarter ending December 31, 2017, were C$266,182 up 2% sequentially over the previous quarter ending September 31, C$271,405. Total revenues increased 2% for the same time period with sales in the recent quarter of C$4.5 million over the previous quarter revenues of C$4.4 million.
Cannabis testing company EVIO, Inc. (EVIO), announced that it expects to double the number of its cannabis testing laboratories from 9 to 18 in the coming year.